Milestone Pharmaceuticals Inc. (MIST): Price and Financial Metrics
MIST Price/Volume Stats
| Current price | $1.29 | 52-week high | $2.75 |
| Prev. close | $1.22 | 52-week low | $0.63 |
| Day low | $1.22 | Volume | 1,043,000 |
| Day high | $1.32 | Avg. volume | 1,965,017 |
| 50-day MA | $1.32 | Dividend yield | N/A |
| 200-day MA | $1.63 | Market Cap | 68.97M |
MIST Stock Price Chart Interactive Chart >
Milestone Pharmaceuticals Inc. (MIST) Company Bio
Milestone Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. It designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.
MIST Price Returns
| 1-mo | N/A |
| 3-mo | -39.44% |
| 6-mo | -30.27% |
| 1-year | -26.07% |
| 3-year | -76.84% |
| 5-year | -62.39% |
| YTD | -45.34% |
| 2024 | 41.32% |
| 2023 | -57.83% |
| 2022 | -39.54% |
| 2021 | -2.24% |
| 2020 | -58.15% |
Loading social stream, please wait...